Theranos inks insurance deal; Illumina farms animal health market with genetic tests;

> Theranos struck a deal with a Pennsylvania insurer to become its preferred lab-work provider. Story

> Illumina ($ILMN) inked an agreement with animal health outfit Neogen ($NEOG) to market its genetic tests to labs. More

> PDI's ($PDII) Interpace Diagnostics unit snagged a positive coverage decision from Aetna ($AET) for its thyroid mutation panel. Statement

> Lexington, MA-based Quanterix is mulling an IPO to ramp up development for its blood biomarker diagnostic device. Story

> Accelerate Diagnostics nabbed a CE mark for its rapid infectious disease testing system. More

> OraSure Technologies ($OSUR) subsidiary DNA Genotek got an EU blessing for its microbiome collection kit. Statement

And Finally… A Philadelphia startup is developing a card-sized, flushable pregnancy test. Story